Skip to main content
Clinical Trials/NCT01627353
NCT01627353
Terminated
Phase 4

Post Hysterectomy Pain Prevention: Randomized Clinical Trial of High Volume Preoperative Wound Infiltration and Pain Specific Anesthetic Protocol Versus Standard of Care (no Wound Infiltration and Routine Anesthetic Protocol)

University of Calgary1 site in 1 country16 target enrollmentJanuary 2012
ConditionsHysterectomy

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hysterectomy
Sponsor
University of Calgary
Enrollment
16
Locations
1
Primary Endpoint
Post Operative Morphine
Status
Terminated
Last Updated
11 years ago

Overview

Brief Summary

The study is a blinded randomized clinical trial, comparing policies of high volume preemptive wound infiltration with a specific anesthetic cocktail versus standard of care (no wound infiltration and routine anesthesia) for post operative pain management after hysterectomy. Morphine use and pain will be measured during index admission, and pain will also be measured six weeks postoperatively. The study will be conducted at a single site, Rockyview General Hospital.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
March 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wynne Innez Leung

Clinical Assistant Professor, General

University of Calgary

Eligibility Criteria

Inclusion Criteria

  • women may be included if they require total abdominal hysterectomies (+/- BSO) at Rockyview hospital.

Exclusion Criteria

  • have endometrial cancer,
  • require a vertical midline incision,
  • have any additional surgery planned
  • have a contraindication to morphine, Magnesium Sulfate, Dexmethasone, Lidocaine or Marcaine
  • have difficulty communicating in English

Outcomes

Primary Outcomes

Post Operative Morphine

Time Frame: For the entire post-operative hospital admission (3 days on average)

The amount of post operative morphine (PCA IV) will be recorded from the PCA device each day by the Acute Pain Service Nurses. The total dose (mg morphine) will be recorded for each 24 hour period, and summed for the complete postoperative period of admission.

Secondary Outcomes

  • Time in recovery (hours)(Until discharge from recovery (on average 2 hours))
  • Morphine use in recovery(Until discharge from recovery (on average 2 hours))
  • Adverse events as a result of morphine overdosage(Until discharge from recovery (on average 2 hours))
  • Change in pain score(baseline - 6 weeks post-operative)
  • Pain measurement using Visual Analogue Scale (VAS) post operatively(Daily until discharge (3 days on average))

Study Sites (1)

Loading locations...

Similar Trials